The Life History of 21 Breast Cancers

Cited by (1,000)

Items 801–900 of 1,000

1. Copy number evolution with weighted aberrations in cancer
   Ron Zeira, Benjamin J. Raphael · 2020 · Bioinformatics
2. Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
   Andreas Venizelos, Christina Engebrethsen, Wei Deng, Jürgen Geisler, Stephanie Beate Geisler, Gjertrud T. Iversen, Turid Aas, Hildegunn Siv Aase, Manouchehr Seyedzadeh, Eli Sihn Samdal Steinskog et al. · 2022 · Genome Medicine
3. Methyl Sulfone Manifests Anticancer Activity in a Metastatic Murine Breast Cancer Cell Line and in Human Breast Cancer Tissue - Part I: Murine 4T1 (66cl-4) Cell Line
   Joan McIntyre Caron, Marissa Bannon, Lindsay Rosshirt, Lisa O'Donovan · 2013 · Chemotherapy
4. Modeling the evolution space of breakage fusion bridge cycles with a stochastic folding process
   Chris Greenman, Susanna L. Cooke, John Marshall, Michael R. Stratton, Peter J. Campbell · 2015 · Journal of Mathematical Biology
5. Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review
   Oraianthi Fiste, Michael Liontos, Konstantinos Koutsoukos, Evangelos Terpos, Meletios Athanasios Dimopoulos, Flora Zagouri · 2020 · Annals of Translational Medicine
6. Longer Survival in Patients with Breast Cancer with Cyclin D1 Over-Expression after Tumor Recurrence: Longer, but Occupied with Disease
   Jaesik Chung, Hany Noh, Kwang Hwa Park, Eun Hee Choi, Airi Han · 2014 · Journal of Breast Cancer
7. Pan-cancer analysis of whole genomes reveals driver rearrangements promoted by LINE-1 retrotransposition in human tumours
   Bernardo Rodríguez–Martín, Eva G. Álvarez, Adrian Baez‐Ortega, Jorge Zamora, Fran Supek, Jonas Demeulemeester, Martín Santamarina, Young Seok Ju, Javier Temes, Daniel García Souto et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
8. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma
   Richard Culliford, Samuel E.D. Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex J. Cornish, Lisa Browning, Ben Kinnersley, Robert B. Bentham, Amit Sud et al. · 2024 · Nature Communications
9. High-Throughput Gene Expression and Mutation Profiling: Current Methods and Future Perspectives
   Thomas Karn · 2013 · Breast Care
10. 8thAnnual European Antibody Congress 2012
    Alain Beck, Paul J. Carter, Hans‐Peter Gerber, Alexey A. Lugovskoy, Thierry Wurch, Jagath Reddy Junutula, Roland E. Kontermann, Robert Mabry · 2013 · mAbs
11. Visualizing Clonal Evolution in Cancer
    Martin I. Krzywinski · 2016 · Molecular Cell
12. Clonal approaches to understanding the impact of mutations on hematologic disease development
    Jyoti Nangalia, Emily Mitchell, Anthony Richard Green · 2019 · Blood
13. Genetic Load and Potential Mutational Meltdown in Cancer Cell Populations
    Yuezheng Zhang, Yawei Li, Xu Shen, Tianqi Zhu, Yong Tao, Yong Tao, Xueying Li, Di Wang, Qin Ma, Zheng Hu et al. · 2018 · Molecular Biology and Evolution
14. High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival
    Jouni Kujala, Jaana M. Hartikainen, Maria Tengström, Reijo K Sironen, Veli‐Matti Kosma, Arto Mannermaa · 2020 · Cancer Medicine
15. Distribution of copy number variations and rearrangement endpoints in human cancers with a review of literature
    Golrokh Mirzaei, Ruben C. Petreaca · 2021 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
16. Next Generation Sequencing in Cancer Research and Clinical Application
    Derek Shyr, Qi Liu · 2014 · Apple Academic Press eBooks
17. Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens
    Yusuke Oku, Federica Madia, Pierre Lau, Martin Paparella, Timothy J. McGovern, Mirjam Luijten, Miriam Naomi Jacobs · 2022 · International Journal of Molecular Sciences
18. Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis
    Rachel E. Ellsworth, Allyson L. Toro, Heather L. Blackburn, Alisha Decewicz, Brenda Deyarmin, Kimberly A. Mamula, Nicholas S. Costantino, Jeffrey A. Hooke, Craig D. Shriver, Darrell L. Ellsworth · 2015 · Cancer Growth and Metastasis
19. Capture‐based next‐generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing
    Jing Xie, Xiongxiong Lu, Xue Wu, Xiaoyi Lin, Chao Zhang, Xiaofang Huang, Zhili Chang, Xinjing Wang, Chenlei Wen, Xiaomei Tang et al. · 2016 · Molecular Genetics & Genomic Medicine
20. What do we need to know and understand about p53 to improve its clinical value?
    Salomao, Norman, Karakostis, Konstantinos, Hupp, Ted, Vollrath, Friz, Vojtesek, Borivoj, Fahraeus, Robin · 2021 · The Journal of Pathology
21. Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1
    Thomas R. W. Oliver, Andrew R. J. Lawson, Henry Lee-Six, Anna Tollit, Hyunchul Jung, Yvette E. Hooks, Rashesh Sanghvi, Matthew D. Young, Timothy M. Butler, Pantelis A. Nicola et al. · 2025 · Nature Genetics
22. Genomic landscape of diffuse glioma revealed by whole genome sequencing
    Ben Kinnersley, Josephine Jung, Alex J. Cornish, Daniel Chubb, Ross C. Laxton, Anna Frangou, Andreas J Gruber, Amit Sud, Giulio Caravagna, Andrea Sottoriva et al. · 2025 · Nature Communications
23. The early-onset cancer epidemics: evidence synthesis using the prospective cohort incident-tumor biobank method
    Shuji Ogino, Satoko Ugai, Tsuyoshi Hamada, Tomotaka Ugai · 2025 · European Journal of Epidemiology
24. Whole-genome landscapes of 1,364 breast cancers
    Ryul Kim, Jonghan Yu, Joonoh Lim, Baek‐Lok Oh, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Byung Joo Chae, Ji‐Yeon Kim, Ga Eun Park et al. · 2025 · Nature
25. Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma
    Tongwu Zhang, Zhao Wei, Christopher Wirth, Marcos Díaz‐Gay, Jinhu Yin, Monia Cecati, Francesca Marchegiani, Phuc H. Hoang, Charles Leduc, Marina K. Baine et al. · 2025 · Nature
26. Reconstructing cell lineage trees with genomic barcoding: approaches and applications
    Zizhang Li, Wenjing Yang, Peng Wu, Yuyan Shan, Xiaoyu Zhang, Feng Chen, Junnan Yang, Jian-Rong Yang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
27. Mutational topography reflects clinical neuroblastoma heterogeneity
    Elias Rodríguez-Fos, Mercè Planas-Fèlix, Martin Burkert, Montserrat Puiggròs, Joern Toedling, Nina Thiessen, Eric Blanc, Annabell Szymansky, Falk Hertwig, Naveed Ishaque et al. · 2023 · Cell Genomics
28. Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity
    Thomas B.K. Watkins, Emma Colliver, Matthew R. Huska, Tom L. Kaufmann, Emilia L. Lim, Cody B. Duncan, Kerstin Haase, Peter Van Loo, Charles Swanton, Nicholas McGranahan et al. · 2023 · PLoS Computational Biology
29. Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics—a comprehensive review
    Shahnawaz Ahmad Bhat, Vijay Kumar, Daljeet Singh Dhanjal, Yashika Gandhi, Sujeet K. Mishra, Simranjeet Singh, Thomas Jay Webster, Praveen Chandrashekarapura Ramamurthy · 2024 · Discover Nano
30. Identification of 2R-ohnologue gene families displaying the same mutation-load skew in multiple cancers
    Michele Tinti, Kumara Dissanayake, Silvia A. Synowsky, Luca Albergante, Carol MacKintosh · 2014 · Open Biology
31. Inferring Intra-tumor Heterogeneity from High-Throughput DNA Sequencing Data
    Layla Oesper, Ahmad Mahmoody, Benjamin J. Raphael · 2013 · Lecture notes in computer science
32. Seeking the driver in tumours with apparent normal molecular profile on comparative genomic hybridization and targeted gene panel sequencing: what is the added value of whole exome sequencing?
    Sophie C. Postel-Vinay, Yannick Boursin, Christophe Massard, Antoine Hollebecque, E. Ileana, Marielle Chiron, Joonil Jung, J.S. Lee, Zsófia Balogh, Julien Adam et al. · 2015 · Annals of Oncology
33. MethCNA: a database for integrating genomic and epigenomic data in human cancer
    Gaofeng Deng, Jian Yang, Qing Zhang, Zhi‐Xiong Jim Xiao, Haoyang Cai · 2018 · BMC Genomics
34. Concordance of Genomic Variants in Matched Primary Breast Cancer, Metastatic Tumor, and Circulating Tumor DNA: The MIRROR Study
    Fernando Moreno, Javier Gayarre, Sara López‐Tarruella, Marı́a del Monte-Millán, Antoni C. Picornell, Enrique L. Álvarez, José Á. García-Sáenz, Yolanda Jerez, Iván Márquez‐Rodas, Isabel Echavarría et al. · 2019 · JCO Precision Oncology
35. Primary Systemic Treatment in the Management of Operable Breast Cancer: Best Surgical Approach for Diagnosis, Biological Evaluation, and Research
    Peter A. Barry, Gaia Schiavon · 2015 · JNCI Monographs
36. Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma
    Amir Farmanbar, Sanaz Firouzi, Wojciech Makałowski, ROBERT W. KNELLER, Masako Iwanaga, Atae Utsunomiya, Kenta Nakai, Toshiki Watanabe · 2018 · Neoplasia
37. The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology
    Federica Natali, Giulia Irene Rancati · 2019 · Frontiers in Genetics
38. Tumor Archaeology Reveals that Mutations Love Company
    Sunita R. Setlur, Charles Lee · 2012 · Cell
39. Mutational signatures reveal mutual exclusivity of homologous recombination and mismatch repair deficiencies in colorectal and stomach tumors
    Amir Farmanbar, ROBERT W. KNELLER, Sanaz Firouzi · 2023 · Scientific Data
40. Intra-tumoral spatial heterogeneity in breast cancer quantified using high-dimensional protein multiplexing and single cell phenotyping
    Alison Cheung, Dan Wang, Mary Anne Quintayo, Yulia Yerofeyeva, Melanie Spears, John M.S. Bartlett, Lincoln David Stein, Jane Bayani, Martin J. Yaffe · 2025 · Breast Cancer Research
41. Functional Genomic Analysis of Breast Cancer Metastasis: Implications for Diagnosis and Therapy
    Ziqi Yu, Mei Ling Song, Lotfi Chouchane, Xiaojing Ma · 2021 · Cancers
42. Accurate Identification of Subclones in Tumor Genomes
    Navid Ahmadinejad, Shayna Troftgruben, Junwen Wang, Pramod Bharadwaj Chandrashekar, Valentin Dinu, Carlo C. Maley, Li Liu · 2022 · Molecular Biology and Evolution
43. Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer RevealsTP53Aneuploidy–driven Metabolic Reprogramming
    Marni B. McClure, Yasunori Kogure, Naser Ansari‐Pour, Yuki Saito, Hann‐Hsiang Chao, Jonathan H. Shepherd, Mariko Tabata, Olufunmilayo Ibironke Olopade, David C. Wedge, Katherine A. Hoadley et al. · 2023 · Cancer Research Communications
44. Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors
    George Miles, James Michael Rae, Suresh S. Ramalingam, John D. Pfeifer · 2015 · Seminars in Oncology
45. Chromosome Imbalances in Cancer: Molecular Cytogenetics Meets Genomics
    Elisa Palumbo, Antonella Russo · 2016 · Cytogenetic and Genome Research
46. Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer
    Peng‐Chan Lin, Yu‐Min Yeh, Bo‐Wen Lin, Shao-Chieh Lin, Ren‐Hao Chan, Po-Chuan Chen, Meng‐Ru Shen · 2020 · Frontiers in Oncology
47. Molecular correlates of immune cytolytic subgroups in colorectal cancer by integrated genomics analysis
    Constantinos Roufas, Ilias Georgakopoulos‐Soares, Apostolos Zaravinos · 2021 · NAR Cancer
48. A model of phenotypic state dynamics initiates a promising approach to control heterogeneous malignant cell populations
    Margaret P. Chapman, Tyler Risom, Anil J. Aswani, Roel Dobbe, Rosalie C. Sears, Claire Jennifer Tomlin · 2016 · IEEE Conference on Decision and Control (CDC)
49. Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigree
    Kiran Tawana, Jun Wang, Péter Attila Király, Krisztián Miklós Kállay, Gábor Benyó, Marianna Zombori, Judit Csomor, Ahad Al Seraihi, Ana Rio‐Machín, András Matolcsy et al. · 2017 · European Journal of Human Genetics
50. SigsPack, a package for cancer mutational signatures
    Franziska Schumann, Eric Blanc, Clemens Messerschmidt, Thomas J. F. Blankenstein, Antonia Busse, Dieter Beule · 2019 · BMC Bioinformatics
51. Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data
    Ingrid M. Lönnstedt, Franco Caramia, Jason Li, Debora Fumagalli, Roberto Salgado, Andrew Rowan, Max Salm, Nnennaya Kanu, Peter Stephen Savas, Stuart D. Horswell et al. · 2014 · Genome biology
52. scAbsolute: measuring single-cell ploidy and replication status
    Michael P Schneider, Amy E Cullen, Justina Pangonyte, Jason Skelton, Harvey Major, Elke Van Oudenhove, María J. García, Blas Chaves-Urbano, Anna Piskorz, James D. Brenton et al. · 2024 · Genome biology
53. Molecular biology in breast cancer: Should molecular classifiers be assessed by conventional tools or by gene expression arrays?
    Debora Fumagalli, Fabrice André, Martine J Piccart, Christos P. Sotiriou, Christine Desmedt · 2012 · Critical Reviews in Oncology/Hematology
54. BubbleTree: an intuitive visualization to elucidate tumoral aneuploidy and clonality using next generation sequencing data
    Wei Ping Zhu, Michael A. Kuziora, Todd H. Creasy, Zhongwu Lai, Christopher A. Morehouse, Xiang Guo, Yinong Sebastian, Dong Shen, Jiaqi Huang, Jonathan R. Dry et al. · 2015 · Nucleic Acids Research
55. MIPUP: minimum perfect unmixed phylogenies for multi-sampled tumors via branchings and ILP
    Edin Husić, Xinyue Li, Ademir Hujdurović, Miika M. Mehine, Roméo Rizzi, Veli Mäkinen, Martin Milanič, Alexandru Ioan Tomescu · 2018 · Bioinformatics
56. Single‐molecule detection of cancer mutations using a novel PCR‐LDR‐qPCR assay
    Cristian Ruiz, Jianmin Huang, Sarah F. Giardina, Philip B. Feinberg, Aashiq Hussain Mirza, Manny D. Bacolod, Steven A. Soper, Francis Barany · 2020 · Human Mutation
57. Reconstructing tumor evolutionary histories and clone trees in polynomial-time with SubMARine
    Linda K. Sundermann, Jeff A. Wintersinger, Gunnar Rätsch, Jens Stoye, Quaid Morris · 2021 · PLoS Computational Biology
58. Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort
    Daniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, Marta Lionetti, Elisa Fermo, Valentina Bellani, Claudio De Magistris, Akihiro Maeda, Alessio Marella, Massimo Primignani et al. · 2023 · Annals of Hematology
59. Evolutionary determinants of curability in cancer
    Marcela Braga Mansur, Nandita M. deSouza, Rachael Natrajan, Lisa M. Abegglen, Joshua David Schiffman, Melvyn F. Greaves · 2023 · Nature Ecology & Evolution
60. Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
    Anssi Nurminen, Serafiina Jaatinen, Sinja Taavitsainen, Gunilla Högnäs, Tom Lesluyes, Naser Ansari‐Pour, Teemu T. Tolonen, Kerstin Haase, Antti Koskenalho, Matti Kankainen et al. · 2023 · Genome Medicine
61. Mutation, clonal fitness and field change in epithelial carcinogenesis
    Julia Frede, David J. Adams, Philip H. Jones · 2014 · The Journal of Pathology
62. HES5 silencing is an early and recurrent change in prostate tumourigenesis
    Charles E. Massie, Inmaculada Spiteri, Helen Ross‐Adams, Hayley J. Luxton, Jonathan D. Kay, Hayley C. Whitaker, Mark Dunning, Alastair D.G. Lamb, Antonio Ramos‐Montoya, Daniel S. Brewer et al. · 2015 · Endocrine Related Cancer
63. Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
    Wensheng Zhang, Yan Dong, Oliver A. Sartor, Kun Zhang · 2022 · Cancer Informatics
64. Proton and alpha radiation-induced mutational profiles in human cells
    Tiffany Myriam Delhomme, Maia Munteanu, Manuela Buonanno, Veljko Grilj, Josep Biayna, Fran Supek · 2023 · Scientific Reports
65. Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer
    Shefali Thakur, Syed Aleem Haider, Rachael Natrajan · 2023 · The Journal of Pathology
66. Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction
    Adriana Salcedo, Maxime Tarabichi, Alex Buchanan, Shadrielle M. G. Espiritu, Hongjiu Zhang, Kaiyi Zhu, Tai-Hsien Ou Yang, Ignaty Leshchiner, Dimitris Anastassiou, Yuanfang Guan et al. · 2024 · Nature Biotechnology
67. The Germline and Somatic Origins of Prostate Cancer Heterogeneity
    Takafumi N. Yamaguchi, Kathleen E. Houlahan, Helen Zhu, Natalie Jayne Kurganovs, Julie M. Livingstone, Natalie S. Fox, Jiapei Yuan, Jocelyn Sietsma Penington, Chol-Hee Jung, Tommer Schwarz et al. · 2025 · Cancer Discovery
68. Malignant CRTC1 :: TRIM11 Cutaneous Tumor With Lethal Outcome: Histopathologic and Molecular Findings
    Meghan Beatson, James William Smithy, Dylan Domenico, Gunes Gundem, Elli Papaemmanouil, Andrea Primiani Moy, Joyce M. Chen, Melissa P. Pulitzer, Charlotte Eielson Ariyan, Klaus Johannes BUSAM · 2025 · Journal of Cutaneous Pathology
69. Complexity and Algorithms for Finding a Perfect Phylogeny from Mixed Tumor Samples
    Ademir Hujdurović, Urša Kačar, Martin Milanič, Bernard Ries, Alexandru Ioan Tomescu · 2016 · IEEE Transactions on Computational Biology and Bioinformatics
70. Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma
    Xiaoyan Chen, Jun Lu, Yingying Wu, Xingran Jiang, Yajuan Gu, Yunlong Li, Hongying Zhao, Mulan Jin · 2020 · Oncology Letters
71. Molecular portraits of lung cancer evolution
    Tikvah K. Hayes, Matthew M. Meyerson · 2023 · Nature
72. Breast cancers as ecosystems: a metabolic perspective
    Flavia Martino, Mariadomenica Lupi, Enrico Giraudo, Letizia Lanzetti · 2023 · Cellular and Molecular Life Sciences
73. Towards accurate characterization of clonal heterogeneity based on structural variation
    Xian Fan, Wanding Zhou, Zechen Chong, Luay K. Nakhleh, Ken Chen · 2014 · BMC Bioinformatics
74. Comparison of Outcomes between Women with De novo Stage IV and Relapsed Breast Cancer
    Dai Kitagawa, Shinichiro Horiguchi, Toshinari Yamashita, Katsumasa Kuroi, Kazuo Shimizu · 2014 · Journal of Nippon Medical School
75. Functional chromatin features are associated with structural mutations in cancer
    Krzysztof R. Grzȩda, Béryl Royer‐Bertrand, Koichiro Inaki, Hyunsoo Kim, Axel M. Hillmer, Edison T. Liu, Jeffrey H. Chuang · 2014 · BMC Genomics
76. Exploitation of adaptive evolution in glioma treatment
    Ryan Cordner, Keith L. Black, Christopher J. Wheeler · 2013 · CNS Oncology
77. Improvement in detection of minor alleles in next generation sequencing by base quality recalibration
    Shengyu Ni, Mark Stoneking · 2016 · BMC Genomics
78. Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer
    Sophie R. Wang, Simeen Malik, Iain Beehuat Tan, Yang Sun Chan, Qiangze Hoi, Jack Ling Ow, Cassandra Zhengxuan He, Cindy E. Ching, Dianne Poh, Hui-Maan Seah et al. · 2016 · Journal of Molecular Diagnostics
79. From Mfd to TRCF and Back Again—A Perspective on Bacterial Transcription‐coupled Nucleotide Excision Repair
    Alexandra M. Deaconescu, Margaret M. Suhanovsky · 2016 · Photochemistry and Photobiology
80. Standard and Genomic Tools for Decision Support in Breast Cancer Treatment
    Norah Lynn Henry, Philippe Lucien Bedard, Angela M. DeMichele · 2017 · American Society of Clinical Oncology Educational Book
81. The evolving role of receptors as predictive biomarkers for metastatic breast cancer
    Carlos Martínez-Pérez, Arran Turnbull, J. Michael Dixon · 2018 · Expert Review of Anticancer Therapy
82. RF-Net 2: fast inference of virus reassortment and hybridization networks
    Alexey Markin, Sanket Wagle, Tavis K. Anderson, Oliver Eulenstein · 2022 · Bioinformatics
83. Evolution and social epidemiology
    Akihiro Nishi · 2015 · Social Science & Medicine
84. BayCount: A Bayesian decomposition method for inferring tumor heterogeneity using RNA-Seq counts
    Fangzheng Xie, Mingyuan Zhou, Yanxun Xu · 2018 · The Annals of Applied Statistics
85. Characterizing the Cancer Genome in Blood
    Sarah‐Jane Dawson · 2018 · Cold Spring Harbor Perspectives in Medicine
86. Reply to ‘Currently available bulk sequencing data do not necessarily support a model of neutral tumor evolution’
    Benjamin Werner, Marc J. Williams, Chris P. Barnes, Trevor A. Graham, Andrea Sottoriva · 2018 · Nature Genetics
87. Genetic inhibitors of APOBEC3B-induced mutagenesis
    Tony M. Mertz, Elizabeth Rice-Reynolds, Ly Thi Huong Nguyen, Anna J. Wood, Cameron Cordero, Nicholas Bray, Victoria Harcy, Rudri K Vyas, Debra Mitchell, Kirill S. Lobachev et al. · 2023 · Genome Research
88. The mutagenic forces shaping the genomic landscape of lung cancer in never smokers
    Marcos Díaz‐Gay, Tongwu Zhang, Phuc H. Hoang, Azhar Khandekar, Wei Zhao, Christopher D. Steele, Burçak Otlu, Shuvro Prokash Nandi, Raviteja Vangara, Erik N. Bergstrom et al. · 2024 · medRxiv
89. Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution
    Michelle Dietzen, Hao-Ran Zhai, Olivia Lucas, Oriol Pich, Christopher Barrington, Wei-Ting Lu, Sophia Ward, Yanping Guo, Robert E. Hynds, Simone Zaccaria et al. · 2024 · Nature Communications
90. CD4 + FOXP3Exon2 + regulatory T cell frequency predicts breast cancer prognosis and survival
    Clorinda Fusco, Francesca Di Rella, Antonietta Liotti, Alessandra Colamatteo, Anne Lise Ferrara, Vincenzo Gigantino, Francesca Collina, Emanuela Esposito, Ivana Donzelli, Antonio Porcellini et al. · 2025 · Science Advances
91. Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency
    Brzozowska, Natalia, Wu, Lily Y. D., Khodzhaeva, Vera, Griffiths, William J., Duckworth, Adam, Jung, Hyunchul, Coorens, Tim H. H., Hooks, Yvette, Chambers, Joseph E., Campbell, Peter J. et al. · 2025 · Nature Genetics
92. APOBEC affects tumor evolution and age at onset of lung cancer in smokers
    Tongwu Zhang, Jian Sang, Phuc H. Hoang, Zhao Wei, Jennifer Rosenbaum, Kofi Ennu Johnson, Leszek J. Klimczak, John P. McElderry, Alyssa Klein, Christopher Wirth et al. · 2025 · Nature Communications
93. Methodological Advancements for Investigating Intra-tumoral Heterogeneity in Breast Cancer at the Bench and Bedside
    Mokryun L. Baek, Jeffrey T. Chang, Gloria Vittone Echeverria · 2020 · Journal of Mammary Gland Biology and Neoplasia
94. Cancer du sein luminal et apport des classifications intrinsèques moléculaires : comment identifier les tumeurs luminales A et B en 2015 ?
    Camille Franchet, Raphaëlle Duprez-Paumier, Magali Lacroix‐Triki · 2015 · Bulletin du Cancer
95. Sequence error storms and the landscape of mutations in cancer
    Stefan Kirsch, Christoph A. Klein · 2012 · Proceedings of the National Academy of Sciences
96. Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence, Recommendations, and Ethical Issues regarding Dual HER2-Targeted Therapy
    Eugene R. Ahn, Emilie Wang, Stefan Glück · 2012 · Breast Cancer Basic and Clinical Research
97. High‐fidelity of non‐small cell lung cancer xenograft models derived from bronchoscopy‐guided biopsies
    Shuai Fu, Jun Zhao, Hua Bai, Jianchun Duan, Zhijie Wang, Tongtong An, Jie Wang · 2015 · Thoracic Cancer
98. Real‐world data in the molecular era—finding the reality in the real world
    DJ Dickson, JD Pfeifer · 2015 · Clinical Pharmacology & Therapeutics
99. Random-walk enzymes
    Chi H. Mak, Phuong Pham, Samir A. Afif, Myron F. Goodman · 2015 · Physical Review E
100. Whole‐exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women
     Xia Li, Hailiang Huang, Yanfang Guan, Yuhua Gong, Chengyi He, Xin Yi, Ming Qi, Zhi‐Ying Chen · 2016 · Cancer Medicine